LONDON, March 11 (Reuters) - Private equity house CVC is set to buy Italian generic drugs firm Doc Genericifrom fellow buyout firm Charterhouse, a sourcefamiliar with the matter said on Friday.
Reuters had previously reported that the supplier ofcardiovascular, cancer and other drugs could be valued atbetween 650 million euros ($727.09 million) and 700 millioneuros.
An announcement could come as soon as Friday, the sourcesaid. Charterhouse is being advised by HSBC, as well asRothschild and Banca IMI, while CVC is being advisedby BNP Paribas.
Charterhouse and CVC were not immediately available tocomment. ($1 = 0.8940 euros) (Reporting By Freya Berry; editing by Sinead Cruise)